AI, AMD and Absci
AMD invests $20M in AI-powered drug discovery company Absci
Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop new hardware and software optimized for the healthcare sector. The effort will place particular emphasis on developing technologies that can advance drug discovery.
Absci Stock Jumps As AMD Invests $20M To Boost AI Drug Discovery
AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the company entered into a strategic collaboration with Advanced Micro Devices Inc (NASDAQ:AMD) to enhance its AI drug discovery capabilities.
12mon MSN
We recently compiled a list of the 12 Best Technology Stocks to Invest In for the Long Term. In this article, we are going to ...
Artificial intelligence (AI) has come a long way in recent years. Businesses are starting to see tangible savings from ...
In an internal test, AMD used the Ryzen AI Max+ 395 to run a version of the Llama 70B large language model. The company says ...
We recently compiled a list of the 14 AI Stocks Making Waves on Wall Street. In this article, we are going to take a look at ...
Artificial intelligence (AI) stocks have soared over the last couple of years as optimism about the technology and its capabilities continues to grow. As most investors know, one ...
One of the pillars of a smart city is an effective transportation system. Tallinn has many interesting projects such as the regional projects with AuveTech self-driving busses and collaboration with ...
We recently published a list of 10 AI Stocks on Investors’ Radar In January 2025. In this article, we are going to take a ...
It's clear that AMD isn't the AI company Nvidia is. Its $3.5 billion in data center revenue in Q3 was a fraction of Nvidia's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback